Browse

You are looking at 1 - 10 of 2,813 items for

  • Refine by Content Type: Articles x
Clear All Modify Search
Meera P. Suthar

The role of advanced practice providers (APPs) has evolved over the last few decades, with data showing that APPs in nephrology can directly improve kidney outcomes in patients with chronic kidney disease (1). The population of kidney transplant recipients (KTRs) in the United States is growing annually, and in 2021, the United Network for Organ Sharing reported the largest number of organ transplants completed in a single year (2). With the exception of 2020, which was affected due to the COVID-19 pandemic, kidney transplants have increased 8 consecutive years in a row (3) (

Meera P. Suthar

The role of advanced practice providers (APPs) has evolved over the last few decades, with data showing that APPs in nephrology can directly improve kidney outcomes in patients with chronic kidney disease (1). The population of kidney transplant recipients (KTRs) in the United States is growing annually, and in 2021, the United Network for Organ Sharing reported the largest number of organ transplants completed in a single year (2). With the exception of 2020, which was affected due to the COVID-19 pandemic, kidney transplants have increased 8 consecutive years in a row (3) (

Fatima Ali, Mital Jhaveri, and Sheila Sarnoski-Brocavich
Is atrial fibrillation (AF) in patients on dialysis an actual effector of cardioembolic events, or is it a surrogate marker for cardiovascular disease?

Overall, direct oral anticoagulants (DOACs) have a superior benefit to a risk profile compared with vitamin K antagonists (VKAs), such as warfarin. When it comes to patients on hemodialysis (HD), however, the confusion lies in which, if any, anticoagulants are appropriate. Patients receiving maintenance HD have a high incidence of stroke, which typically warrants the use of anticoagulation. However, patients on HD also have an increased risk of bleeding because they are routinely heparinized three times each

Fatima Ali, Mital Jhaveri, and Sheila Sarnoski-Brocavich
Is atrial fibrillation (AF) in patients on dialysis an actual effector of cardioembolic events, or is it a surrogate marker for cardiovascular disease?

Overall, direct oral anticoagulants (DOACs) have a superior benefit to a risk profile compared with vitamin K antagonists (VKAs), such as warfarin. When it comes to patients on hemodialysis (HD), however, the confusion lies in which, if any, anticoagulants are appropriate. Patients receiving maintenance HD have a high incidence of stroke, which typically warrants the use of anticoagulation. However, patients on HD also have an increased risk of bleeding because they are routinely heparinized three times each

Tod Ibrahim

Over its nearly 60-year history, the American Society of Nephrology (ASN) has approached the tripartite mission in phases, starting first with providing medical education, then advocating for research and innovation, and more recently, ensuring high-quality patient care. ASN's mission is to “elevate care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world (1).

Today, patient care is the tabletop, with education (undergraduate/graduate and continuing), research, and advocacy as the supporting legs. Diversity, equity, and inclusion are the joints that lock aprons (health care justice) to

Mark Rosenberg and Melissa West

The ASN Task Force on the Future of Nephrology was charged with reconsidering all aspects of the future of nephrology to determine how to best prepare nephrology fellows for the challenges and opportunities the future will bring. Since April, the task force has been meeting regularly with the goal of delivering its report by October 2022 to fulfill requests from the American Board of Internal Medicine (ABIM) and the Accreditation Council for Graduate Medical Education (ACGME). These organizations determine what changes should be made to nephrology certification and recertification (ABIM) and fellowship training programs (ACGME). To learn more about the

Priya Yenebere and Amy A. Yau

There is increasing evidence that climate change is associated with kidney diseases, and in turn, kidney disease therapies, namely dialysis, put an additional strain on the environment (1). The narrative review by Bharati and colleagues (2) details the many associations and proposed mechanisms of climate change and kidney diseases (Figure 1). The increase in global temperature and extreme weather coupled with food and water scarcity is associated with acute kidney injury, kidney stones, and chronic kidney disease. Beyond the direct effect of heat injury and dehydration, population migration and industrialization lead to urban heat

Priya Yenebere and Amy A. Yau

There is increasing evidence that climate change is associated with kidney diseases, and in turn, kidney disease therapies, namely dialysis, put an additional strain on the environment (1). The narrative review by Bharati and colleagues (2) details the many associations and proposed mechanisms of climate change and kidney diseases (Figure 1). The increase in global temperature and extreme weather coupled with food and water scarcity is associated with acute kidney injury, kidney stones, and chronic kidney disease. Beyond the direct effect of heat injury and dehydration, population migration and industrialization lead to urban heat

Linda Awdishu

Pharmacists are essential drug experts on the health care team, providing clinical services related to safe distribution, optimal selection, and use of medications and patient education in the community, ambulatory care, and acute care pharmacy environments.

Pharmacists are trained at accredited schools of pharmacy that require a minimum of 2–4 years of undergraduate education before entering a 3- to 4-year doctorate training program (PharmD). During their doctorate training, they are licensed as pharmacy interns and begin gaining practice experience in the community and acute care settings, working under the supervision of a licensed pharmacist. After completing the PharmD degree, although

Linda Awdishu

Pharmacists are essential drug experts on the health care team, providing clinical services related to safe distribution, optimal selection, and use of medications and patient education in the community, ambulatory care, and acute care pharmacy environments.

Pharmacists are trained at accredited schools of pharmacy that require a minimum of 2–4 years of undergraduate education before entering a 3- to 4-year doctorate training program (PharmD). During their doctorate training, they are licensed as pharmacy interns and begin gaining practice experience in the community and acute care settings, working under the supervision of a licensed pharmacist. After completing the PharmD degree, although